Mutations of drug target molecules in Pneumocystis jirovecii isolates and future investigations

Japanese Journal of Medical Mycology

Volumn 50, Issue 2, 2009, Pages 67-73

  Takahashi, Takashi ^a  

^a Tokyo Metropolitan Health and Medical Treatment Corporation   (Japan)

Author keywords

Drug target molecules; Genotype; Phenotype; Pneumocystis jirovecii; Pneumocystis pneumonia

Indexed keywords

ATOVAQUONE; COTRIMOXAZOLE; CYTOCHROME B; DIHYDROFOLATE REDUCTASE; DIHYDROPTEROATE SYNTHASE; PENTAMIDINE; PTERIN; SULFAMETHOXAZOLE; SULFONAMIDE; TRIMETHOPRIM;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; DRUG BINDING; DRUG SENSITIVITY; DRUG TARGETING; DRUG TREATMENT FAILURE; ENZYME INHIBITION; FUNGUS ISOLATION; GENOTYPE; HUMAN; MORTALITY; MUTATIONAL ANALYSIS; NONHUMAN; PHENOTYPE; PNEUMOCYSTIS JIROVECI; PNEUMOCYSTIS PNEUMONIA; REVIEW;

ADULT; AGED; ATOVAQUONE; DIHYDROPTEROATE SYNTHASE; DRUG DELIVERY SYSTEMS; FEMALE; HUMANS; MALE; MIDDLE AGED; MUTATION; PENTAMIDINE; PNEUMOCYSTIS JIROVECII; PNEUMONIA, PNEUMOCYSTIS; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION;

FUNGI; PNEUMOCYSTIS; PNEUMOCYSTIS JIROVECII;

EID: 66249097079     PISSN: 09164804     EISSN: None     Source Type: Journal    
DOI: 10.3314/jjmm.50.067     Document Type: Review

References (14)

1. Takahashi T, Hoshino Y, Nakamura T, Iwamoto A: Mediastinal emphysema with Pneumocystis carinii pneumonia in AIDS. Am J Roentgenol 169: 1465-1466, 1997.
2. Takahashi T, Goto M, Endo T, Nakamura T, Yusa N, Sato N, Iwamoto A : Pneumocystis carinii carriage in immunocompromised patients with and without human immunodeficiency virus infection. J Med Microbiol 51: 611-614, 2002.
3. Taguchi H, Takahashi T, Wada Y, Nakamura T, Iwamoto A: Pentamidine-induced hemolytic anemia in an AIDS patient. Ann Pharmacother 33: 503, 1999. (Pubitemid 29215820)
4. Takahashi T, Hosoya N, Endo T, Nakamura T, Sakashita H, Kimura K, Ohnishi K, Nakamura Y, Iwamoto A: Relationship between mutations in dihydropteroate synthase of Pneumocystis carinii f. sp. hominis isolates in Japan and resistance to sulfonamide therapy. J Clin Microbiol 38: 3161-3164, 2000.
5. Takahashi T, Endo T, Nakamura T, Sakashita H, Kimura K, Ohnishi K, Kitamura Y, Iwamoto A: Dihydrofolate reductase gene polymorphisms in Pneumocystis carinii f. sp. hominis in Japan. J Med Microbiol 51: 510-515, 2002. (Pubitemid 34492980)
6. Takahashi T, Kanda T, Iwamoto A: Genetic diversity of drug targets including dihydropteroate synthase, dihydrofolate reductase and cytochrome b, in Pneumocystis carinii f. sp. hominis isolates in Japan. Res Commun Mol Pathol Pharmacol 112: 159-176, 2002. (Pubitemid 38352363)
7. Dallas WS, Gowen JE, Ray PH, Cox MJ, Dev IK: Cloning, sequencing, and enhanced expression of the dihydropteroate synthase gene of Escherichia coli MC4100. J Bacteriol 174: 5961-5970, 1992.
8. Kazanjian P, Armstrong W, Hossler PA, Burman W, Richardson J, Lee CH, Crane L, Katz J, Meshnick SR: Pneumocystis carinii mutations are associated with duration of sulfa or sulfone prophylaxis exposure in AIDS patients. J Infect Dis 182: 551-557, 2000.
9. Ma L, Kovacs JA, Cargnel A, Valerio A, Fantoni G, Atzori C: Mutations in the dihydropteroate synthase gene of human-derived Pneumocystis carinii isolates from Italy are infrequent but correlate with prior sulfa prophylaxis. J Infect Dis 185: 1530-1532, 2002.
10. Navin TR, Beard CB, Huang L, del Rio C, Lee S, Pieniazek NJ, Carter JL, Le T, Hightower A, Rimland D: Effect of mutations in Pneumocystis carinii dihydropteroate synthase gene on outcome of P. carinii pneumonia in patients with HIV-1: a prospective study. Lancet 358: 545-549, 2001.
11. Hosoya N, Takahashi T, Wada M, Endo T, Nakamura T, Sakashita T, Kimura K, Ohnishi K, Nakamura Y, Mizuochi T, Iwamoto A: Genotyping of Pneumocystis carinii f. sp. hominis isolates in Japan based on nucleotide sequence variations in internal transcribed spacer regions of rRNA genes. Microbiol Immunol 44: 591-596, 2000.
12. Kessl JJ, Hill P, Lange BB, Meshnick SR, Meunier B, Trumpower BL: Molecular basis for atovaquone resistance in Pneumocystis jirovecii modeled in the cytochrome bc (1) complex of Saccharomyces cerevisiae. J Biol Chem 279: 2817-2824, 2004.